Expanding the breadth, magnitude, and durability of PfSPZ vaccines by creating multi-strain vaccines, designer hybrid and genetically altered parasite vaccines and use of a unique adjuvant.
A glycolipid adjuvant to promote dose sparing, accelerate immunization schedules and extend durability of high-level protection with an attenuated, live sporozoite malaria vaccine
Chakravarty, Sumana et al.·SANARIA, INC.·ROCKVILLE, MD
These grants mention Malaria as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.
Other(44)
OtherUM1Active
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
